Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Brainstorm Cell Therapeutics Inc. Stock Forecast NASDAQ:BCLI
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2021-02-05 | - | Maxim Group | - | Upgrades | Hold Buy |
BCLI Stock Trend
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.
Given the current short-term trend, the stock is expected to fall -8.56% during the next 3 months and, with a 90% probability hold a price between $2.44 and $3.14 at the end of this 3-month period.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-25 | $2.66 | $3.04 | $3.42 |
| 2022-05-26 | $2.66 | $3.04 | $3.42 |
| 2022-05-27 | $2.65 | $3.03 | $3.41 |
| 2022-05-31 | $2.65 | $3.03 | $3.41 |
| 2022-06-01 | $2.64 | $3.02 | $3.40 |
| 2022-06-02 | $2.64 | $3.02 | $3.40 |
| 2022-06-03 | $2.63 | $3.01 | $3.39 |
| 2022-06-06 | $2.63 | $3.01 | $3.39 |
| 2022-06-07 | $2.62 | $3.00 | $3.38 |
| 2022-06-08 | $2.62 | $3.00 | $3.38 |
| 2022-06-09 | $2.61 | $2.99 | $3.37 |
| 2022-06-10 | $2.60 | $2.99 | $3.37 |
| 2022-06-13 | $2.60 | $2.98 | $3.36 |
| 2022-06-14 | $2.59 | $2.98 | $3.36 |
| 2022-06-15 | $2.59 | $2.97 | $3.35 |
| 2022-06-16 | $2.58 | $2.96 | $3.35 |
| 2022-06-17 | $2.58 | $2.96 | $3.34 |
| 2022-06-21 | $2.57 | $2.95 | $3.34 |
| 2022-06-22 | $2.57 | $2.95 | $3.33 |
| 2022-06-23 | $2.56 | $2.94 | $3.32 |
| 2022-06-24 | $2.56 | $2.94 | $3.32 |
| 2022-06-27 | $2.55 | $2.93 | $3.31 |
| 2022-06-28 | $2.55 | $2.93 | $3.31 |
| 2022-06-29 | $2.54 | $2.92 | $3.30 |
| 2022-06-30 | $2.54 | $2.92 | $3.30 |
| 2022-07-01 | $2.53 | $2.91 | $3.29 |
| 2022-07-05 | $2.53 | $2.91 | $3.29 |
| 2022-07-06 | $2.52 | $2.90 | $3.28 |
| 2022-07-07 | $2.52 | $2.90 | $3.28 |
| 2022-07-08 | $2.51 | $2.89 | $3.27 |
Brainstorm Cell Therapeutics Inc., a biotechnology company, develops adult stem cell therapies for neurodegenerative disorders. It holds rights to develop and commercialize its NurOwn technology through a licensing agreement with Ramot of Tel Aviv University Ltd. The companys NurOwn technology is based on a novel differentiation protocol, which induces differentiation of the bone marrow-derived mesenchymal stem cells into neuron-supporting cell... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
